PMID:8434007: Difference between revisions
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php |
imported>Wikientrybot change PMID template to TableEdit version |
||
| Line 1: | Line 1: | ||
{{RightTOC}} | {{RightTOC}} | ||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd--> | |||
<!-- | |||
****************************************************************************************** | |||
* | |||
* ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | |||
* | |||
****************************************************************************************** --> | |||
{| id="P522399c9959fd" class=" tableEdit PMID_info_table" | |||
|- | |||
!align=left |Citation | |||
|| | |||
'''No author listed''' (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. ''Proc. Natl. Acad. Sci. U.S.A.'' '''90''':1474-8 | |||
|- | |||
!align=left |Abstract | |||
|| | |||
The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute lymphoblastic leukemia, has been determined at 2.3 A resolution by using data from a single heavy atom derivative in combination with molecular replacement. The atomic model was refined to an R factor of 0.143. This enzyme, active as a homotetramer with 222 symmetry, belongs to the class of alpha/beta proteins. Each subunit has two domains with unique topological features. On the basis of present structural evidence consistent with previous biochemical studies, we propose locations for the active sites between the N- and C-terminal domains belonging to different subunits and postulate a catalytic role for Thr-89. | |||
|- | |||
!align=left |Links | |||
|| | |||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8434007 PubMed] [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC45896 PMC45896] | |||
|- | |- | ||
| | !align=left |Keywords | ||
|| | |||
|- | Amino Acid Sequence; Asparaginase/chemistry; Asparaginase/therapeutic use; Binding Sites; Escherichia coli/enzymology; Humans; Macromolecular Substances; Models, Molecular; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Protein Conformation; Protein Structure, Secondary; Threonine; X-Ray Diffraction | ||
|{{ | |||
|- class="tableEdit_footer" | |||
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd&page=132176&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> || | |||
|} | |} | ||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd--> | |||
==Significance {{HelpIcon|Help:Literature}} == | ==Significance {{HelpIcon|Help:Literature}} == | ||
{{LitSignificance}} | {{LitSignificance}} | ||
Revision as of 19:47, 1 September 2013
| Citation |
No author listed (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 90:1474-8 |
|---|---|
| Abstract |
The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute lymphoblastic leukemia, has been determined at 2.3 A resolution by using data from a single heavy atom derivative in combination with molecular replacement. The atomic model was refined to an R factor of 0.143. This enzyme, active as a homotetramer with 222 symmetry, belongs to the class of alpha/beta proteins. Each subunit has two domains with unique topological features. On the basis of present structural evidence consistent with previous biochemical studies, we propose locations for the active sites between the N- and C-terminal domains belonging to different subunits and postulate a catalytic role for Thr-89. |
| Links | |
| Keywords |
Amino Acid Sequence; Asparaginase/chemistry; Asparaginase/therapeutic use; Binding Sites; Escherichia coli/enzymology; Humans; Macromolecular Substances; Models, Molecular; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Protein Conformation; Protein Structure, Secondary; Threonine; X-Ray Diffraction |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.